Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in JAMA Retrieve available abstracts of 257 articles: HTML format

Single Articles

July 2024
1. HARRIS E
   Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
   JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
   PubMed    
   
   
   
2. RUBIN R
   Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
   JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
   PubMed    
   
   
   
3. 
   The Conquest of Yellow Fever.
   JAMA. 2024;332:175.
   PubMed    
   
   
   June 2024
4. HARRIS E
   WHO: As Mpox Outbreaks Continue, Cases May Be Underestimated.
   JAMA. 2024;331:2070.
   PubMed    
   
   
   
5. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
   Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
   JAMA. 2024;331:2127-2128.
   PubMed    
   
   
   
6. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
   Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
   JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
   PubMed    
   
   
   
7. DEAN N, Amin AB
   Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
   JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.5633.
   PubMed    
   
   
   May 2024
8. HARRIS E
   Lower Dose of Mpox Vaccine Was Safe, Effective.
   JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
   PubMed    
   
   
   
9. HARRIS E
   Microneedle Vaccine Patches Generated Immune Response in Children.
   JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
   PubMed    
   
   
   
10. QATO DM, Romley JA, Myerson R, Goldman D, et al
    Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing.
    JAMA. 2024 May 23. doi: 10.1001/jama.2024.7348.
    PubMed    
    
    
    
11. HARRIS E
    CDC Warns of Surge in Meningococcal Disease in US.
    JAMA. 2024;331:1614.
    PubMed    
    
    
    
12. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed    
    
    
    
13. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    PubMed    
    
    
    
14. HARRIS E
    Five-in-One Meningitis Vaccine Rolls Out.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7727.
    PubMed    
    
    
    
15. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed    
    
    
    April 2024
16. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    PubMed    
    
    
    
17. VOELKER R
    What Is Hepatitis D Infection?
    JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.1317.
    PubMed    
    
    
    
18. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    PubMed    
    
    
    
19. HARRIS E
    Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5153.
    PubMed    
    
    
    
20. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    PubMed    
    
    
    
21. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    PubMed    
    
    
    
22. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
    PubMed    
    
    
    March 2024
23. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    PubMed    
    
    
    
24. EDWARDS KM, Griffin MR
    Postmarketing Vaccine Safety Assessments: Important Work in Progress.
    JAMA. 2024;331:915-917.
    PubMed    
    
    
    
25. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    PubMed     Abstract available
    
    
    
26. HARRIS E
    WHO Issues First Recommendations for Managing Diphtheria.
    JAMA. 2024;331:907.
    PubMed    
    
    
    
27. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    PubMed    
    
    
    
28. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    PubMed    
    
    
    February 2024
29. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    PubMed    
    
    
    
30. JAMIESON KH, Johnson KB, Cappola AR
    Misinformation and the Vaccine Adverse Event Reporting System.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2024.1757.
    PubMed    
    
    
    
31. HARRIS E
    New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0731.
    PubMed    
    
    
    
32. HARRIS E
    Africa's First Routine Malaria Vaccination Campaign Begins.
    JAMA. 2024 Feb 7. doi: 10.1001/jama.2024.0170.
    PubMed    
    
    
    
33. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    PubMed     Abstract available
    
    
    
34. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    PubMed     Abstract available
    
    
    January 2024
35. HARRIS E
    Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
    PubMed    
    
    
    
36. HARRIS E
    CDC Warns of Low Vaccination Rates Amid Spike in Respiratory Diseases.
    JAMA. 2024 Jan 17. doi: 10.1001/jama.2023.27428.
    PubMed    
    
    
    
37. MARKS P, Califf R
    Is Vaccination Approaching a Dangerous Tipping Point?
    JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
    PubMed    
    
    
    
38. HARRIS E
    High-Dose Flu Vaccine May Be More Effective for Midlife Adults.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26114.
    PubMed    
    
    
    December 2023
39. RUBIN R
    Despite Safe and Effective Vaccine, Measles Cases and Deaths Increased Worldwide From 2021 to 2022.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25527.
    PubMed    
    
    
    
40. RUBIN R
    Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
    PubMed    
    
    
    November 2023
41. HARRIS E
    FDA Approves First Chikungunya Vaccine.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23505.
    PubMed    
    
    
    
42. HARRIS E
    Measles Outbreaks Grow Amid Declining Vaccination Rates.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23511.
    PubMed    
    
    
    
43. HARRIS E
    Live-Virus Shingles Vaccine Provided Some Long-Term Protection.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23507.
    PubMed    
    
    
    
44. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
    JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
    PubMed     Abstract available
    
    
    
45. HARRIS E
    Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
    PubMed    
    
    
    
46. HARRIS E
    FDA Will Evaluate First Self-Administered FluMist Vaccine.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870.
    PubMed    
    
    
    
47. MALANI P
    Highlights From IDWeek 2023-New Vaccines, Artificial Intelligence, and Antimicrobial Resistance.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.19291.
    PubMed    
    
    
    October 2023
48. HARRIS E
    Vaccination Hesitancy Increasing Among Pregnant Women.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19800.
    PubMed    
    
    
    
49. HARRIS E
    Trial Launches of New HIV Vaccine Candidate With CMV Vector.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19203.
    PubMed    
    
    
    
50. DELAMATER PL, Buttenheim AM, Salmon DA, Schwartz JL, et al
    Kindergarten Vaccination Status in California After Changes to Medical Exemption Policy.
    JAMA. 2023 Oct 2:e2316995. doi: 10.1001/jama.2023.16995.
    PubMed    
    
    
    September 2023
51. HARRIS E
    NIH Launches Phase 1 Trial of Broader "Universal" Flu Vaccine.
    JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18741.
    PubMed    
    
    
    
52. HARRIS E
    Southern Hemisphere Outcomes Support Flu Vaccine Effectiveness.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17822.
    PubMed    
    
    
    
53. RUBIN R
    Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
    JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
    PubMed    
    
    
    
54. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
    Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
    PubMed    
    
    
    
55. HARRIS E
    HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
    PubMed    
    
    
    
56. HARRIS E
    CDC Recommends RSV Immunization for Infants.
    JAMA. 2023;330:797.
    PubMed    
    
    
    August 2023
57. HARRIS E
    FDA Approves Maternal RSV Vaccine.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106.
    PubMed    
    
    
    July 2023
58. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
    PubMed    
    
    
    
59. GOSTIN LO, Reiss D, Mello MM
    Vaccination Mandates-An Old Public Health Tool Faces New Challenges.
    JAMA. 2023 Jul 24. doi: 10.1001/jama.2023.11059.
    PubMed    
    
    
    
60. HARRIS E
    First Ever Malaria Vaccine to Be Distributed in Africa.
    JAMA. 2023 Jul 19. doi: 10.1001/jama.2023.12549.
    PubMed    
    
    
    
61. HARRIS E
    CDC: RSV Vaccine Recommended for Older People.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12537.
    PubMed    
    
    
    
62. RUBIN R
    This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
    PubMed    
    
    
    June 2023
63. HARRIS E
    Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10738.
    PubMed    
    
    
    
64. 
    Public Health: An Interesting Parliamentary Debate on Vaccination.
    JAMA. 2023;329:2099.
    PubMed    
    
    
    
65. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
    BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
    JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
    PubMed    
    
    
    
66. HARRIS E
    Hybrid COVID-19 Immunity Common by Fall of 2022.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
    PubMed    
    
    
    
67. DESAI AN, Malani PN
    JYNNEOS Vaccine for Mpox.
    JAMA. 2023;329:1995.
    PubMed    
    
    
    May 2023
68. HARRIS E
    COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
    PubMed    
    
    
    
69. HARRIS E
    FDA Clears RSV Vaccine for Adults Aged 60 Years or Older.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8657.
    PubMed    
    
    
    
70. DENG L, Lopez LK, Glover C, Cashman P, et al
    Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox.
    JAMA. 2023 May 5. doi: 10.1001/jama.2023.7683.
    PubMed    
    
    
    
71. HARRIS E
    BCG Vaccine Not Effective Against COVID-19.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
    PubMed    
    
    
    April 2023
72. HARRIS E
    FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
    PubMed    
    
    
    
73. HARRIS E
    How Parents' Views Are Tied to Children's COVID-19 Vaccination.
    JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
    PubMed    
    
    
    
74. HARRIS E
    RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6254.
    PubMed    
    
    
    
75. HARRIS E
    Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
    PubMed    
    
    
    
76. AMMIRATI E, Moslehi JJ
    Diagnosis and Treatment of Acute Myocarditis: A Review.
    JAMA. 2023;329:1098-1113.
    PubMed     Abstract available
    
    
    March 2023
77. ZHOU YB
    Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine.
    JAMA. 2023;329:1031.
    PubMed    
    
    
    
78. HAZRA A, Schneider JA
    Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine-Reply.
    JAMA. 2023;329:1032.
    PubMed    
    
    
    
79. HARRIS E
    Cost-effective Global Strep B Vaccination Would Prevent Infant Deaths.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4005.
    PubMed    
    
    
    
80. SURAN M
    Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession-Even If It Doesn't Become Law.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3401.
    PubMed    
    
    
    
81. SO S, Terrault N, Conners EE
    Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.2806.
    PubMed    
    
    
    February 2023
82. FLANNERY DD, Zevallos Barboza A, Wade KC, Pfeifer MR, et al
    Measles Serostatus Among Parturient Patients at 2 Philadelphia Hospitals in 2021.
    JAMA. 2023;329:682-684.
    PubMed    
    
    
    
83. HARRIS E
    COVID-19 Vaccination During Pregnancy Protected Infants.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
    PubMed    
    
    
    
84. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
    PubMed     Abstract available
    
    
    
85. HARRIS E
    Marburg Vaccine Safe, Immunogenic in Phase 1 Trial.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1343.
    PubMed    
    
    
    
86. RUBIN R
    Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
    PubMed    
    
    
    
87. CHU WM, Wang CY, Wei JC
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2023;329:426.
    PubMed    
    
    
    
88. HUH K, Kim YE, Jung J
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
    JAMA. 2023;329:426-427.
    PubMed    
    
    
    
89. SURAN M
    New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2022.23242.
    PubMed    
    
    
    
90. LARKIN H
    Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
    PubMed    
    
    
    January 2023
91. ROLFES MA, Talbot HK, McLean HQ, Stockwell MS, et al
    Household Transmission of Influenza A Viruses in 2021-2022.
    JAMA. 2023 Jan 26. doi: 10.1001/jama.2023.0064.
    PubMed     Abstract available
    
    
    
92. RUBIN R
    Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0050.
    PubMed    
    
    
    
93. SLOMSKI A
    Ebola Vaccines Safe and Immunogenic in 2 Trials.
    JAMA. 2023;329:278-279.
    PubMed    
    
    
    
94. SLOMSKI A
    Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants.
    JAMA. 2023;329:279.
    PubMed    
    
    
    
95. MCCARTHY MW, Naggie S, Boulware DR, Lindsell CJ, et al
    Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.24100.
    PubMed     Abstract available
    
    
    
96. LARKIN H, Larkin H
    Twenty-Strain "Universal" mRNA Flu Vaccine Effective in Animal Studies.
    JAMA. 2023;329:114.
    PubMed    
    
    
    
97. LARKIN H
    Whole-Sporozoite Malaria Vaccine Candidate Shows Real-world Promise.
    JAMA. 2023;329:115.
    PubMed    
    
    
    December 2022
98. SLOMSKI A
    Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.
    JAMA. 2022;328:2388.
    PubMed    
    
    
    
99. LARKIN H
    WHO: Vaccine Market Report Highlights Inequitable Global Distribution.
    JAMA. 2022;328:2294.
    PubMed    
    
    
    
100. WALTER K, Malani PN
     What Is Measles?
     JAMA. 2022;328:2370.
     PubMed    
     
     
     
101. ABBASI J
     Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic.
     JAMA. 2022 Dec 15. doi: 10.1001/jama.2022.23241.
     PubMed    
     
     
     
102. LARKIN H
     Investigational RSV Vaccine Given During Pregnancy Protects Newborns.
     JAMA. 2022;328:2201.
     PubMed    
     
     
     
103. MARKS PW, Gruppuso PA, Adashi EY
     Urgent Need for Next-Generation COVID-19 Vaccines.
     JAMA. 2022 Dec 9. doi: 10.1001/jama.2022.22759.
     PubMed    
     
     
     
104. LARKIN HD
     Novavax COVID-19 Vaccine Booster Authorized.
     JAMA. 2022;328:2101.
     PubMed    
     
     
     
105. MANMADHAN A, Ahuja T
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association.
     JAMA. 2022;328:2164-2165.
     PubMed    
     
     
     
106. MACK CD, Anderson DJ, DiFiori J
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association-Reply.
     JAMA. 2022;328:2165.
     PubMed    
     
     
     November 2022
107. SLOMSKI A
     Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
     JAMA. 2022;328:2003.
     PubMed    
     
     
     
108. KUEHN BM
     Targeted Flu Vaccination Campaigns Needed for Certain Racial and Ethnic Groups.
     JAMA. 2022;328:2005.
     PubMed    
     
     
     
109. RUBIN R
     Vaccine Approved in Pregnancy to Protect Young Infants.
     JAMA. 2022;328:1898.
     PubMed    
     
     
     
110. LARKIN HD
     WHO Backs Single Dose of Hepatitis A Vaccine in Some Cases.
     JAMA. 2022;328:1896.
     PubMed    
     
     
     
111. LARKIN HD
     Studies Find Single Dose of HPV Vaccines May Be Effective.
     JAMA. 2022;328:1896.
     PubMed    
     
     
     
112. KUEHN BM
     Shifting Hepatitis A Epidemiology Requires Renewed Vaccination Efforts.
     JAMA. 2022;328:1800.
     PubMed    
     
     
     
113. KUEHN BM
     Single Monkeypox Vaccine Dose Provides Some Protection.
     JAMA. 2022;328:1801.
     PubMed    
     
     
     
114. KUEHN BM
     Second COVID-19 Booster Increases Protection for Nursing Home Patients.
     JAMA. 2022;328:1800-1801.
     PubMed    
     
     
     October 2022
115. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
     Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
     PubMed     Abstract available
     
     
     
116. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
     Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
     JAMA. 2022;328:1523-1533.
     PubMed     Abstract available
     
     
     
117. BELLANDI D
     Rotavirus Leads Global Diarrhea Hospitalizations Among Young Children.
     JAMA. 2022;328:1490.
     PubMed    
     
     
     
118. LARKIN HD
     Progress on Replication-Defective Live Virus Vaccines.
     JAMA. 2022;328:1387.
     PubMed    
     
     
     
119. KUEHN BM
     Catch-up Vaccinations Needed for Some Adolescents.
     JAMA. 2022;328:1389-1390.
     PubMed    
     
     
     
120. ABBASI J
     White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
     JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.
     PubMed    
     
     
     September 2022
121. HAZRA A, Rusie L, Hedberg T, Schneider JA, et al
     Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine.
     JAMA. 2022 Sep 30. pii: 2797135. doi: 10.1001/jama.2022.18320.
     PubMed    
     
     
     
122. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
     Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
     JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
     PubMed     Abstract available
     
     
     
123. TENFORDE MW, Link-Gelles R, Patel MM
     Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
     JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
     PubMed    
     
     
     
124. LIN DY, Gu Y, Xu Y, Wheeler B, et al
     Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
     JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
     PubMed     Abstract available
     
     
     
125. RIDGWAY JP, Tideman S, French T, Wright B, et al
     Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
     JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.
     PubMed    
     
     
     
126. RUBIN R
     The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
     JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
     PubMed    
     
     
     
127. LARKIN HD
     Backslide in Global Childhood Vaccinations.
     JAMA. 2022;328:1029.
     PubMed    
     
     
     
128. LARKIN HD
     New Data on Heterologous COVID-19 Vaccine Combinations.
     JAMA. 2022;328:916-917.
     PubMed    
     
     
     
129. LARKIN HD
     FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access.
     JAMA. 2022;328:819.
     PubMed    
     
     
     
130. CULLEN JP, Russ S, Russell HA
     Theater for Vaccine Hesitancy-Setting the Stage for Difficult Conversations.
     JAMA. 2022 Sep 2. pii: 2796160. doi: 10.1001/jama.2022.14864.
     PubMed    
     
     
     August 2022
131. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
     Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
     JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
     PubMed     Abstract available
     
     
     
132. RUBIN R
     Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
     JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
     PubMed    
     
     
     
133. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
     Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
     JAMA. 2022;328:637-651.
     PubMed     Abstract available
     
     
     
134. LARKIN HD
     New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
     JAMA. 2022;328:518.
     PubMed    
     
     
     
135. KUEHN BM
     More Effective Flu Vaccines Recommended for Older Adults.
     JAMA. 2022;328:519.
     PubMed    
     
     
     July 2022
136. KIM YE, Huh K, Park YJ, Peck KR, et al
     Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
     JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
     PubMed    
     
     
     
137. LARKIN HD
     Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
     JAMA. 2022;328:234.
     PubMed    
     
     
     
138. KUEHN BM
     Newer Poxvirus Vaccine Is Recommended.
     JAMA. 2022;328:123.
     PubMed    
     
     
     
139. RUBIN R
     COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
     JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
     PubMed    
     
     
     
140. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
     Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
     JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
     PubMed    
     
     
     June 2022
141. ABBASI J
     COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
     JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
     PubMed    
     
     
     
142. LARKIN HD
     mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
     JAMA. 2022;327:2280.
     PubMed    
     
     
     
143. LARKIN HD
     Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
     JAMA. 2022;327:2182.
     PubMed    
     
     
     
144. KATZ SE, Edwards K
     Protecting Children Against Omicron.
     JAMA. 2022;327:2195-2197.
     PubMed    
     
     
     
145. JONES JM, Opsomer JD, Stone M, Benoit T, et al
     Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
     JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
     PubMed    
     
     
     
146. LI Y
     Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
     JAMA. 2022;327:2147-2148.
     PubMed    
     
     
     
147. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
     JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
     PubMed    
     
     
     
148. RUBIN R
     Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
     JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
     PubMed    
     
     
     May 2022
149. WEISS SR
     Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
     JAMA. 2022;327:2019-2020.
     PubMed    
     
     
     
150. OSTER ME, Shay DK, Shimabukuro TT
     Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
     JAMA. 2022;327:2020-2021.
     PubMed    
     
     
     
151. KUEHN BM
     Cardiac Complications More Common After COVID-19 Than Vaccination.
     JAMA. 2022;327:1951.
     PubMed    
     
     
     
152. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
     Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
     JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
     PubMed     Abstract available
     
     
     
153. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
     Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
     JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
     PubMed    
     
     
     
154. LARKIN HD
     Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
     JAMA. 2022;327:1748.
     PubMed    
     
     
     
155. LARKIN HD
     Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
     JAMA. 2022;327:1748.
     PubMed    
     
     
     
156. KUEHN BM
     Age Range Is Expanded for Universal Hepatitis B Vaccination.
     JAMA. 2022;327:1749.
     PubMed    
     
     
     
157. KUEHN BM
     mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
     JAMA. 2022;327:1749.
     PubMed    
     
     
     
158. SLOMSKI A
     Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
     JAMA. 2022;327:1641.
     PubMed    
     
     
     
159. MARKS P, Woodcock J, Califf R
     COVID-19 Vaccination-Becoming Part of the New Normal.
     JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
     PubMed    
     
     
     April 2022
160. KUEHN BM
     COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
     JAMA. 2022;327:1540.
     PubMed    
     
     
     
161. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
     Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
     JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
     PubMed    
     
     
     
162. LARKIN HD
     Fractionating COVID-19 Vaccine Doses May Save Lives.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
163. WOLFSON AR, Freeman EE, Blumenthal KG
     Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
     JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
     PubMed    
     
     
     
164. ABBASI J
     Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
     JAMA. 2022;327:1323.
     PubMed    
     
     
     
165. ABBASI J
     Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
     JAMA. 2022;327:1323.
     PubMed    
     
     
     
166. KUEHN BM
     Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
     JAMA. 2022;327:1324.
     PubMed    
     
     
     
167. SLOMSKI A
     Maternal COVID-19 Vaccine Safe for Infants.
     JAMA. 2022;327:1218.
     PubMed    
     
     
     
168. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
     Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
     JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
     PubMed     Abstract available
     
     
     
169. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
     Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
     JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
     PubMed    
     
     
     March 2022
170. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
     Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
     JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
     PubMed     Abstract available
     
     
     
171. KHARBANDA EO, Vazquez-Benitez G
     COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
     JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
     PubMed    
     
     
     
172. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
     Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
     JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
     PubMed     Abstract available
     
     
     
173. FELL DB, Dhinsa T, Alton GD, Torok E, et al
     Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
     JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
     PubMed     Abstract available
     
     
     
174. SLOMSKI A
     Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
     JAMA. 2022;327:1118.
     PubMed    
     
     
     
175. STEAD W
     One Person.
     JAMA. 2022;327:1131-1132.
     PubMed    
     
     
     
176. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
     Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
     JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
     PubMed    
     
     
     
177. ABBASI J
     First mRNA HIV Vaccine Clinical Trial Launches.
     JAMA. 2022;327:909.
     PubMed    
     
     
     
178. KUEHN BM
     Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
     JAMA. 2022;327:910.
     PubMed    
     
     
     February 2022
179. ABBASI J
     Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
     JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.
     PubMed    
     
     
     
180. KUEHN BM
     New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
     JAMA. 2022;327:614.
     PubMed    
     
     
     
181. KUEHN BM
     COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
     JAMA. 2022;327:614.
     PubMed    
     
     
     
182. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
     Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
     JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
     PubMed     Abstract available
     
     
     
183. TAN SHX, Pung R, Wang LF, Lye DC, et al
     Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
     JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.
     PubMed    
     
     
     
184. ABBASI J
     Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
     JAMA. 2022;327:517.
     PubMed    
     
     
     
185. KUEHN BM
     Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
     JAMA. 2022;327:518.
     PubMed    
     
     
     
186. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
     Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
     JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.
     PubMed    
     
     
     January 2022
187. SURAN M
     Coverage of COVID-19 Vaccine Counseling for Children and Youths.
     JAMA. 2022;327:313.
     PubMed    
     
     
     
188. LI HF, Hu SM, Lv M
     Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
     JAMA. 2022;327:392-393.
     PubMed    
     
     
     
189. WOO EJ, Dimova RB, Mba-Jonas A
     Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
     JAMA. 2022;327:393-394.
     PubMed    
     
     
     
190. OSTER ME, Shay DK, Su JR, Gee J, et al
     Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
     JAMA. 2022;327:331-340.
     PubMed     Abstract available
     
     
     
191. KLOMPAS M, Karan A
     Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
     JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.
     PubMed    
     
     
     
192. ABBASI J, Rubin R, Suran M
     How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
     JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.
     PubMed    
     
     
     
193. OMER SB, Malani PN
     Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
     JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.
     PubMed    
     
     
     
194. GOSTIN LO, Parmet WE, Rosenbaum S
     The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
     JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.
     PubMed    
     
     
     
195. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
     Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
     JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
     PubMed     Abstract available
     
     
     
196. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
     Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
     JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.
     PubMed    
     
     
     
197. KUEHN BM
     Vaccine Development Is Charting a New Path in Malaria Control.
     JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.
     PubMed    
     
     
     
198. KUEHN BM
     Vaccine Passports Help Boost Lagging Vaccination Rates.
     JAMA. 2022;327:209.
     PubMed    
     
     
     
199. ADASHI EY, Cohen IG
     The Pandemic Preparedness Program: Reimagining Public Health.
     JAMA. 2022;327:219-220.
     PubMed    
     
     
     
200. ABBASI J
     Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
     JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.
     PubMed    
     
     
     
201. RUBIN R
     COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
     JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.
     PubMed    
     
     
     
202. ABBASI J
     Studies Suggest COVID-19 Vaccine Boosters Save Lives.
     JAMA. 2022;327:115.
     PubMed    
     
     
     
203. ABBASI J
     Homing In On a SARS-CoV-2 Correlate of Protection.
     JAMA. 2022;327:115.
     PubMed    
     
     
     
204. ABBASI J
     COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
     JAMA. 2022;327:115.
     PubMed    
     
     
     
205. WALD A
     Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
     JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.
     PubMed    
     
     
     
206. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
     Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
     JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
     PubMed     Abstract available
     
     
     
207. BORIO LL, Bright RA, Emanuel EJ
     A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
     JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.
     PubMed    
     
     
     December 2021
208. ABBASI J
     RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
     JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.
     PubMed    
     
     
     
209. 
     Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
     JAMA. 2021;326:2521-2522.
     PubMed    
     
     
     
210. SLOMSKI A
     More Pediatric Data for First Cell-Derived Influenza Vaccine.
     JAMA. 2021;326:2464.
     PubMed    
     
     
     
211. KUEHN BM
     Influenza Vaccination Increased During the COVID-19 Pandemic.
     JAMA. 2021;326:2465.
     PubMed    
     
     
     
212. ABBASI J
     Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
     JAMA. 2021;326:2460-2462.
     PubMed    
     
     
     
213. LAM DL, Flanagan MR
     Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
     JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
     PubMed    
     
     
     
214. DEL RIO C, Omer SB, Malani PN
     Winter of Omicron-The Evolving COVID-19 Pandemic.
     JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.
     PubMed    
     
     
     
215. KUEHN BM
     Vaccination Doesn't Eliminate Delta Variant Household Transmission.
     JAMA. 2021;326:2353.
     PubMed    
     
     
     
216. COHN AC, Mahon BE, Walensky RP
     One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
     JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.
     PubMed    
     
     
     
217. LEVY M, Recher M, Hubert H, Javouhey E, et al
     Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
     JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.
     PubMed    
     
     
     
218. ADAMS LE, Waterman S, Paz-Bailey G
     Vaccination for Dengue Prevention.
     JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.
     PubMed    
     
     
     
219. BATES TA, McBride SK, Winders B, Schoen D, et al
     Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
     JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.
     PubMed    
     
     
     
220. SURAN M
     Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
     JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.
     PubMed    
     
     
     
221. ABBASI J
     COVID-19 Vaccine Combination Was Superior in Real-world Study.
     JAMA. 2021;326:2250.
     PubMed    
     
     
     
222. WALTER K
     COVID-19 and Pregnancy.
     JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.
     PubMed    
     
     
     
223. 
     Current Comment.
     JAMA. 2021;326:2217.
     PubMed    
     
     
     
224. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
     Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
     JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.
     PubMed    
     
     
     
225. ABBASI J
     Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
     JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.
     PubMed    
     
     
     
226. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
     US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
     JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.
     PubMed    
     
     
     November 2021
227. RUBIN R
     COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
     JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
     PubMed    
     
     
     
228. RUBIN R
     Substance Use Disorders and COVID-19 Vaccine Response.
     JAMA. 2021;326:2000.
     PubMed    
     
     
     
229. KUEHN BM
     COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
     JAMA. 2021;326:2002.
     PubMed    
     
     
     
230. KUEHN BM
     Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
     JAMA. 2021;326:2002.
     PubMed    
     
     
     
231. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
     Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
     JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
     PubMed    
     
     
     
232. SFEIR MM, Snayd M
     Serologic Testing for Hepatitis B.
     JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.
     PubMed    
     
     
     
233. CHOR J, Davis AM, Rusiecki JM
     Cervical Cancer Screening Guideline for Individuals at Average Risk.
     JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.
     PubMed    
     
     
     
234. ABBASI J
     Flu Vaccine Candidate Elicits Enhanced Immune Response.
     JAMA. 2021;326:1784.
     PubMed    
     
     
     
235. ABBASI J
     Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
     JAMA. 2021;326:1784.
     PubMed    
     
     
     
236. ABBASI J
     "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
     JAMA. 2021;326:1784.
     PubMed    
     
     
     
237. 
     Routine Smallpox Vaccination.
     JAMA. 2021;326:1876.
     PubMed    
     
     
     
238. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
     Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
     JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
     PubMed    
     
     
     
239. MOSS WJ, Gostin LO, Nuzzo JB
     Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
     JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
     PubMed    
     
     
     
240. KLOMPAS M
     Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
     JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
     PubMed    
     
     
     
241. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
     Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
     JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
     PubMed     Abstract available
     
     
     
242. CROWE EH
     The Taste of Hope.
     JAMA. 2021;326:1683-1684.
     PubMed    
     
     
     
243. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
     Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
     JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
     PubMed    
     
     
     
244. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
     Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
     JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
     PubMed     Abstract available
     
     
     October 2021
245. ABBASI J
     The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
     JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
     PubMed    
     
     
     
246. RUBIN R
     Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
     JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
     PubMed    
     
     
     
247. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
     Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
     JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
     PubMed    
     
     
     
248. ABBASI J
     India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
249. ABBASI J
     Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
250. ABBASI J
     Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
     JAMA. 2021;326:1365.
     PubMed    
     
     
     
251. KUEHN BM
     HPV Vaccination Coverage Has Increased Among Adolescents.
     JAMA. 2021;326:1366.
     PubMed    
     
     
     
252. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
     Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
     JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
     PubMed     Abstract available
     
     
     September 2021
253. RUBIN R
     COVID-19 Vaccine Nasal Spray.
     JAMA. 2021;326:1138.
     PubMed    
     
     
     
254. KRONMAL SL
     Shots in Arms.
     JAMA. 2021;326:1151-1152.
     PubMed    
     
     
     August 2021
255. RUBIN R
     Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
     JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
     PubMed    
     
     
     
256. DETSKY AS, Bogoch II
     COVID-19 in Canada: Experience and Response to Waves 2 and 3.
     JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
     PubMed    
     
     
     
257. DEL RIO C, Malani PN, Omer SB
     Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
     JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.